Home/Filings/4/0001225208-14-023383
4//SEC Filing

WEST PHARMACEUTICAL SERVICES INC 4

Accession 0001225208-14-023383

$WSTCIK 0000105770operating

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 12:43 PM ET

Size

10.7 KB

Accession

0001225208-14-023383

Insider Transaction Report

Form 4
Period: 2014-11-13
GAILEY JOHN R
VP, Gen. Counsel & Sec.
Transactions
  • Sale

    Common Stock

    2014-11-13$52.41/sh8,000$419,28079,891.372 total
  • Exercise/Conversion

    Common Stock

    2014-11-13$21.34/sh+20,000$426,80087,891.372 total
  • Sale

    Common Stock

    2014-11-13$52.36/sh20,000$1,047,20659,891.372 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-11-13$21.34/sh20,000$426,80017,832 total
    Exercise: $21.34From: 2011-03-22Exp: 2020-03-22Common Stock (20,000 underlying)
Holdings
  • Common Stock

    (indirect: By Savings Plan)
    1,463.37
  • Common Stock

    (indirect: Non-Qualified Deferred Compensation Plan)
    11,222.14
Footnotes (1)
  • [F1]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

Documents

1 file

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeoperating
IncorporatedPA

Related Parties

1
  • filerCIK 0000105770

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 12:43 PM ET
Size
10.7 KB